Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
USD | Fiscal Year Ending | | Latest |
(in millions) | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | Dec-24 | | Dec-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 927 | 1,016 | 1,332 | 1,445 | 1,574 | 1,648 | 1,921 | 2,181 | 2,378 | 2,735 | | 2,735 |
% Growth | NA | 9.6% | 31.2% | 8.4% | 9.0% | 4.7% | 16.6% | 13.5% | 9.0% | 15.0% | | |
| | | | | | | | | | | | |
Cost of Revenue | (304) | (338) | (469) | (497) | (532) | (562) | (624) | (684) | (768) | (910) | | (910) |
Gross Profit | 623 | 678 | 863 | 948 | 1,042 | 1,086 | 1,297 | 1,498 | 1,609 | 1,826 | | 1,826 |
% Revenue | 67.2% | 66.7% | 64.8% | 65.6% | 66.2% | 65.9% | 67.5% | 68.7% | 67.7% | 66.7% | | 66.7% |
| | | | | | | | | | | | |
Research and Development | (131) | (143) | (183) | (186) | (196) | (221) | (273) | (308) | (325) | (363) | | (363) |
Selling and Marketing | (226) | (268) | (361) | (413) | (442) | (445) | (536) | (610) | (599) | (642) | | (642) |
General and Admin | (90) | (107) | (128) | (152) | (167) | (179) | (224) | (246) | (257) | (277) | | (277) |
Other Inc / (Exp) | (12) | (19) | (42) | (1) | (2) | (2) | (21) | (0) | 1 | (2) | | (2) |
Total Operating Exp | (459) | (538) | (715) | (752) | (807) | (847) | (1,054) | (1,165) | (1,180) | (1,284) | | (1,284) |
| | | | | | | | | | | | |
Operating Income | 164 | 140 | 149 | 195 | 235 | 239 | 243 | 333 | 429 | 542 | | 542 |
% Revenue | 17.7% | 13.8% | 11.2% | 13.5% | 14.9% | 14.5% | 12.7% | 15.3% | 18.1% | 19.8% | | 19.8% |
| | | | | | | | | | | | |
Interest Expense | 7 | 4 | (19) | (9) | (0) | (2) | (2) | 13 | 28 | 63 | | 63 |
Pre-tax Income | 171 | 144 | 130 | 187 | 234 | 237 | 241 | 345 | 458 | 605 | | 605 |
Earnings of Discontinued Ops. | 118 | (6) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (31) | (21) | 14 | (27) | (48) | (41) | (41) | (79) | (119) | (162) | | (162) |
Net Income to Company | 259 | 117 | 143 | 159 | 186 | 196 | 199 | 266 | 338 | 443 | | 443 |
% Margin | 27.9% | 11.5% | 10.8% | 11.0% | 11.8% | 11.9% | 10.4% | 12.2% | 14.2% | 16.2% | | 16.2% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Net Income to Stockholders | 259 | 117 | 143 | 159 | 186 | 196 | 199 | 266 | 338 | 443 | | 443 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | (118) | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | 141 | 123 | 143 | 159 | 186 | 196 | 199 | 266 | 338 | 443 | | 443 |
% Margin | 15.2% | 12.1% | 10.8% | 11.0% | 11.8% | 11.9% | 10.4% | 12.2% | 14.2% | 16.2% | | 16.2% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 2.36 | 2.06 | 2.37 | 2.60 | 2.99 | 3.13 | 3.15 | 4.17 | 5.32 | 6.97 | | 6.97 |
Diluted EPS (Continuing Ops) | 2.29 | 2.02 | 2.31 | 2.52 | 2.88 | 2.98 | 2.98 | 4.00 | 5.11 | 6.76 | | 6.76 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 59.55 | 59.67 | 60.44 | 61.39 | 62.12 | 62.71 | 63.19 | 63.79 | 63.59 | 63.48 | | 63.48 |
WA Diluted Shares Out. | 61.28 | 61.04 | 62.12 | 63.31 | 64.66 | 65.96 | 66.90 | 66.47 | 66.27 | 65.51 | | 65.51 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 171 | 144 | 130 | 187 | 234 | 237 | 241 | 345 | 458 | 605 | | 605 |
Addback: Net Interest Expense | (7) | (4) | 19 | 9 | 0 | 2 | 2 | (13) | (28) | (63) | | (63) |
Addback: Other Non Operating Expenses, Total | 2 | (3) | 1 | 2 | 4 | 3 | 7 | 1 | 6 | 4 | | 4 |
Addback: Depreciation & Amortization | 58 | 78 | 156 | 157 | 173 | 182 | 184 | 177 | 167 | 205 | | 205 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 9 | 1 | 1 | 1 | 2 | 2 | 0 | 14 | 3 | | 3 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | (0) | (3) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Asset Writedown | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 0 | 0 | 0 | 0 | 0 | 0 | 14 | 1 | (18) | (3) | | (3) |
Adjusted EBITDA | 224 | 221 | 307 | 356 | 413 | 426 | 450 | 512 | 598 | 751 | | 751 |
% Margin | 24.1% | 21.8% | 23.1% | 24.6% | 26.2% | 25.8% | 23.4% | 23.5% | 25.2% | 27.5% | | 27.5% |
| | | | | | | | | | | | |
Adjusted EBIT | 166 | 144 | 151 | 199 | 239 | 244 | 266 | 335 | 431 | 546 | | 546 |
% Margin | 17.9% | 14.1% | 11.3% | 13.8% | 15.2% | 14.8% | 13.8% | 15.4% | 18.1% | 20.0% | | 20.0% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 259 | 117 | 143 | 159 | 186 | 196 | 199 | 266 | 338 | 443 | | 443 |
Addback: Unusual Items | 0 | 6 | 1 | 1 | 1 | 2 | 16 | 1 | (4) | 0 | | 0 |
Less: Tax Benefit of Unusual Items (26%) | (0) | (2) | (0) | (0) | (0) | (0) | (4) | (0) | 1 | (0) | | (0) |
Adjusted Net Income | 259 | 122 | 144 | 160 | 186 | 198 | 211 | 267 | 335 | 443 | | 443 |
% Margin | 28.0% | 12.0% | 10.8% | 11.1% | 11.8% | 12.0% | 11.0% | 12.2% | 14.1% | 16.2% | | 16.2% |